The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

We use cookies to improve your experience and serve personalized ads.

By clicking Accept, you consent to our use of advertising cookies. See our Privacy Policy for details.

Macro EconomyMedium•23 February 2026•

1 min read

Trump Proposes 15% Global Tariff as Eli Lilly Outperforms Novo Nordisk

Emmanuel Macron's face centered between cracked Visa and Mastercard cards, with Euro and Ethereum symbols, bank buildings, and digital payment cards.

Key Facts

1President Trump is raising his threatened global tariff to 15%.

2Eli Lilly triumphs over obesity rival Novo Nordisk once again.

Former President Donald Trump has escalated his trade policy rhetoric by proposing a 15% global tariff on imports. This move signals a potential shift toward more aggressive protectionism, raising concerns about global trade volatility and inflationary pressures. Meanwhile, in the pharmaceutical sector, Eli Lilly continues to solidify its leadership in the lucrative obesity drug market. Recent data suggests Eli Lilly is gaining a competitive edge over its primary rival, Novo Nordisk, as market demand for weight-loss treatments surges. Investors are closely monitoring these developments, as the tariff news weighs on broad market indices like the SPY, while Eli Lilly provides a bullish catalyst for the healthcare sector. The combination of macro geopolitical risks and sector-specific growth highlights a complex landscape for global markets.